Search Results - Philippe Moreau

Refine Results
  1. 1

    Optimal sequencing in the management of relapsed/refractory myeloma patients by Philippe Moreau

    Published in HemaSphere (2018-06-01)
    Get full text
    Article


  2. 2

    La « loi royale » de la première-née (Denys d’Halicarnasse, Antiquités romaines, II, 15, 2) : une règle démographique archaïque ? by Philippe Moreau

    Published in Cahiers Mondes Anciens (2018-01-01)
    Get full text
    Article


  3. 3

    Multiple myeloma: so much progress, but so many unsolved questions by Philippe Moreau, Stéphane Minvielle

    Published in Haematologica (2013-04-01)
    Get full text
    Article


  4. 4

    In search of the optimal proteosome inhibitor. How, when and for whom? by Monika Engelhardt, Sara Bringhen, Philippe Moreau, Ralph Wäsch, Johannes Waldschmidt

    Published in Haematologica (2021-04-01)
    Get full text
    Article


  5. 5

    The Dual Role of HLA-G in Cancer by Nathalie Rouas-Freiss, Philippe Moreau, Joel LeMaoult, Edgardo D. Carosella

    Published in Journal of Immunology Research (2014-01-01)
    Get full text
    Article


  6. 6

    Tribological Performance of AlCrN, TiAlN, and Arc-DLC Coatings in Hot Forming of Aluminum Alloy by Panuwat Soranansri, André Dubois, Philippe Moreau, Tatsuya Funazuka, Kuniaki Dohda, Laurent Dubar

    Published in Lubricants (2025-09-01)
    Get full text
    Article


  7. 7

    Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin... by Thomas Dejoie, Michel Attal, Philippe Moreau, Jean-Luc Harousseau, Herve Avet-Loiseau

    Published in Haematologica (2016-03-01)
    Get full text
    Article


  8. 8

    Transcriptional and Posttranscriptional Regulations of the HLA-G Gene by Erick C. Castelli, Luciana C. Veiga-Castelli, Layale Yaghi, Philippe Moreau, Eduardo A. Donadi

    Published in Journal of Immunology Research (2014-01-01)
    Get full text
    Article


  9. 9

    FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma by Pierre-Yves Salaun, Thomas Gastinne, Eric Frampas, Caroline Bodet-Milin, Philippe Moreau, Françoise Bodéré-Kraeber

    Published in Haematologica (2008-08-01)
    Get full text
    Article


  10. 10

    Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma by Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Philippe Moreau, Loïc Campion, Benoît Dupas, Steven Le Gouill

    Published in Haematologica (2008-03-01)
    Get full text
    Article


  11. 11

    Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations by Bilal Mohty, Jean El-Cheikh, Ibrahim Yakoub-Agha, Philippe Moreau, Jean-Luc Harousseau, Mohamad Mohty

    Published in Haematologica (2010-02-01)
    Get full text
    Article


  12. 12

    Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma by Philippe Moreau, Valerie Coiteux, Cyrille Hulin, Xavier Leleu, Helgi van de Velde, Milin Acharya, Jean-Luc Harousseau

    Published in Haematologica (2008-12-01)
    Get full text
    Article


  13. 13

    High temperature stress-strain data for SAE 5120 steel under various strain ratesDataverse by Philippe Moreau, Jean-Dominique Guérin, José Grégorio La Barbara Sosa, Eli Puchi Cabrera, André Dubois, Laurent Dubar

    Published in Data in Brief (2025-08-01)
    Get full text
    Article


  14. 14

    Response and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone... by Meletios Dimopoulos, Michael Wang, Vladimir Maisnar, Jiri Minarik, William Bensinger, Maria-Victoria Mateos, Mihaela Obreja, Julie Blaedel, Philippe Moreau

    Published in Journal of Hematology & Oncology (2018-04-01)
    Get full text
    Article


  15. 15

    Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for... by Anne Lok, Julie Mocquard, Jessie Bourcier, Laurence Redelsperger, Antoine Bonnet, Cecile Chauvin, Patrick Thomaré, Beatrice Mahé, Cyrille Touzeau, Philippe Moreau

    Published in Haematologica (2014-03-01)
    Get full text
    Article


  16. 16

    Differential Transcript Profiles of MHC Class Ib(Qa-1, Qa-2, and Qa-10) and Aire Genes during the Ontogeny of Thymus and Other Tissues by Breno Luiz Melo-Lima, Adriane Feijó Evangelista, Danielle Aparecida Rosa de Magalhães, Geraldo Aleixo Passos, Philippe Moreau, Eduardo Antonio Donadi

    Published in Journal of Immunology Research (2014-01-01)
    Get full text
    Article


  17. 17

    Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14) by Cyrille Touzeau, Steven Le Gouill, Béatrice Mahé, Jean Samuel Boudreault, Thomas Gastinne, Nicolas Blin, Hélène Caillon, Christelle Dousset, Martine Amiot, Philippe Moreau

    Published in Haematologica (2017-03-01)
    Get full text
    Article


  18. 18

    Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma by Bertrand Arnulf, Halyna Pylypenko, Sebastian Grosicki, Ievgenii Karamanesht, Xavier Leleu, Helgi van de Velde, Huaibao Feng, Andrew Cakana, William Deraedt, Philippe Moreau

    Published in Haematologica (2012-12-01)
    Get full text
    Article


  19. 19

    An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment by Meletios A. Dimopoulos, Joseph Mikhael, Evangelos Terpos, Xavier Leleu, Philippe Moreau, Joan Bladé, Jin Seok Kim, Keith Stockerl-Goldstein, Paul G. Richardson

    Published in Therapeutic Advances in Hematology (2022-04-01)
    Get full text
    Article


  20. 20

    Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethaso... by Karthik Ramasamy, Nizar J. Bahlis, Shaji K. Kumar, Arun Kumar, Holly Cranmer, Bingxia Wang, Jonathan Dabora, Richard Labotka, Paul G. Richardson, Philippe Moreau

    Published in Haematologica (2024-02-01)
    Get full text
    Article


Search Tools: